Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2026-03-03 @ 8:10 AM
Study NCT ID:
NCT03715166
Status:
TERMINATED
Last Update Posted:
2024-07-25
First Post:
2018-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder
Sponsor:
Institut de Recherches Internationales Servier
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-24
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-13
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-12
First Submit QC Date:
None
Study First Post Date:
2018-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-24
Last Update Post Date:
2024-07-25
Last Update Post Date Type:
ACTUAL